MINDIN secretion by prostate tumors induces premetastatic changes in bone via β-catenin

Endocr Relat Cancer. 2020 Jul;27(7):441-456. doi: 10.1530/ERC-20-0116.

Abstract

Bone metastases are common in advanced prostate cancer patients, but mechanisms by which specific pro-metastatic skeletal niches are formed before tumor cell homing are unclear. We aimed to analyze the effects of proteins secreted by primary prostate tumors on the bone microenvironment before the settlement and propagation of metastases. Here, using an in vivo pre-metastatic prostate cancer model based on the implantation of prostate adenocarcinoma TRAMP-C1 cells in immunocompetent C57BL/6 mice, we identify MINDIN as a prostate tumor secreted protein that induces bone microstructural and bone remodeling gene expression changes before tumor cell homing. Associated with these changes, increased tumor cell adhesion to the endosteum ex vivo and to osteoblasts in vitro was observed. Furthermore, MINDIN promoted osteoblast proliferation and mineralization and monocyte expression of osteoclast markers. β-catenin signaling pathway revealed to mediate MINDIN actions on osteoblast gene expression but failed to affect MINDIN-induced adhesion to prostate tumor cells or monocyte differentiation to osteoclasts. Our study evidences that MINDIN secretion by primary prostate tumors creates a favorable bone environment for tumor cell homing before metastatic spread.

Keywords: MINDIN, bone; pre-metastatic niche; prostate tumor; β-catenin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Extracellular Matrix Proteins / metabolism*
  • Humans
  • Male
  • Mice
  • Neoplasm Proteins / metabolism*
  • Prostatic Neoplasms / metabolism*
  • Transfection
  • beta Catenin / metabolism*

Substances

  • Extracellular Matrix Proteins
  • Neoplasm Proteins
  • SPON2 protein, human
  • beta Catenin